Compare KAZR & USNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KAZR | USNA |
|---|---|---|
| Founded | N/A | 1992 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Engineering & Construction | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 398.1M | 348.6M |
| IPO Year | 2025 | 1996 |
| Metric | KAZR | USNA |
|---|---|---|
| Price | $2.88 | $19.22 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 76.1K | ★ 103.7K |
| Earning Date | N/A | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.41 |
| Revenue | N/A | ★ $1,060,902,000.00 |
| Revenue This Year | N/A | $3.90 |
| Revenue Next Year | N/A | $6.21 |
| P/E Ratio | ★ N/A | $46.10 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.81 | $16.60 |
| 52 Week High | $2.99 | $38.32 |
| Indicator | KAZR | USNA |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 55.41 |
| Support Level | N/A | $18.80 |
| Resistance Level | N/A | $19.48 |
| Average True Range (ATR) | 0.00 | 0.76 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 0.00 | 66.55 |
Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).